Updates

March 2, 2021March 2, 2021
Foundations Merge to Do More for People With Lung Diseases

Two Montreal-based foundations are joining forces to boost research and care into complex and chronic respiratory disorders, including chronic obstructive pulmonary disease (COPD). The merging ... Read more
February 25, 2021February 25, 2021
Partnership Brings Quantitative Imaging Analysis to Diagnosis, Care

A new collaboration is seeking to bring quantitative imaging analysis to diagnosis and care of patients with chronic lung diseases, including chronic obstructive pulmonary disease ... Read more
February 23, 2021February 23, 2021
FDA OKs Pivotal Trial Testing RheOx System in Chronic Bronchitis

The U.S. Food and Drug Administration (FDA) has cleared the start of an international pivotal trial to test the RheOx System, Gala Therapeutics’ medical device, ... Read more
February 18, 2021February 18, 2021
Weight Loss, Low BMI Tied to Worse Mortality in Japanese Men

Weight loss and a low body mass index (BMI) are associated with worse mortality outcomes among men with chronic obstructive pulmonary disease (COPD) in Japan, ... Read more
February 16, 2021February 16, 2021
New Algorithm May Find Misdiagnosis in COPD

A new algorithm-based approach was developed to identify patients at risk of being misdiagnosed with chronic obstructive pulmonary disease (COPD). Researchers believe this may become ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

June 20, 2017June 20, 2017

Tilray Announces Support for Clinical Trial Evaluating Medical Cannabis Efficacy in COPD Patients

News

The effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD) are the target of a new clinical trial that stems from a partnership between medical cannabis products company Tilray and the Research Institute of the McGill University Health ... Read more

Updates

Foundations Merge to Do More for People With Lung Diseases

Partnership Brings Quantitative Imaging Analysis to Diagnosis, Care

FDA OKs Pivotal Trial Testing RheOx System in Chronic Bronchitis

Weight Loss, Low BMI Tied to Worse Mortality in Japanese Men

New Algorithm May Find Misdiagnosis in COPD

Trixeo Aerosphere Approved in Scotland as COPD Maintenance Therapy

American Lung Association Awards $50K for Regenerative Medicine Project

FDA Gives Green Light to Clinical Trial of Zofin

Inhaled Hyaluronan Found to Ease Acute COPD Exacerbations

COPD Foundation, Holy Cross Health Open Program for At-home Care

New Breath Biopsy Panel May Help in COPD Diagnosis

Subscribe to our mailing list

Wellinks’ First Wireless Nebulizer for COPD Cleared for Patient Study

Amoxicillin Alone Better Than Antibiotic Combo for Treating Exacerbations

Noninvasive Home Ventilation Linked to Lower Risk of Death, ER Visits

Study: COPD Treatment in China Relies Too Heavily on Inhaled Corticosteroids

Protein’s Activity Tied to Emphysema, May Link COPD to Lung Cancer

Trixeo Aerosphere Approved in EU for COPD

Inflammatory Biomarkers Distinguish COPD from Asthma-COPD in Some Cases

Partnership Promotes Virtual Pulmonary Rehab Program During Pandemic

American Thoracic Society Publishes New COPD Oxygen Therapy Guidelines

Nuvaira’s Targeted Lung Denervation Therapy Shown to Lower Hospitalization Risk

Wolters Launches Alexa Emmi Care Plan to Enable Close Patient-Clinician Contact

Vaping Linked to Higher Respiratory Disease Risk in Large US Study

Trial Testing RejuvenAir as Chronic Bronchitis Treatment Still Enrolling in Europe

New Therapeutic Target for COPD Identified in Study

Philips Launches Novel Non-invasive Ventilator to Monitor COPD Patients Remotely

Study Examines Success of Noninvasive Ventilation in COPD After Acute Exacerbation

Health Care Service Corporation Now Covering Zephyr Valve in US

FDA Gives Clearance to PulmoScan Device for At-home Lung Function Monitoring

Training in Use of Inhaler Devices Seen to Help Older Patients

RejuvenAir System Tested in 1st Trial Participant With COPD and Chronic Bronchitis

European CHMP Gives Positive Opinion to COPD Therapy Trixeo Aerosphere

Prenatal Smoke Exposure May Increase Baby’s Later COPD Risk, Mouse Study Says

No Link Between Face Masks and CO2 Poisoning, Even in People With COPD, Study Finds

Oral Cannabinoids Linked to Higher Mortality Risk in Older COPD Patients, Study Finds

ATS and 4DMedical Offering Grants for Research in COPD, Other Lung Diseases

Tilray Announces Support for Clinical Trial Evaluating Medical Cannabis Efficacy in COPD Patients